Engineering the (Immune) System

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/50/91/2d/50912d5f-953d-19e1-54ca-e7ef984b12d3/mza_7346862484177431303.jpg/600x600bb.jpg

TomorrowScale Podcast

Justin Briggs

27 episodes

1 week ago

Conversations with the scientists and entrepreneurs who are building the future.

Science

RSS

All content for TomorrowScale Podcast is the property of Justin Briggs and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Conversations with the scientists and entrepreneurs who are building the future.

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/1975639/1975639-1597297011227-4be67595f5592.jpg

Engineering the (Immune) System - DistributedBio

TomorrowScale Podcast

57 minutes 15 seconds

5 years ago

Engineering the (Immune) System - DistributedBio

On today’s episode, we’ll sit down with DistributedBio co-founder and CEO Jacob Glanville, and Centivax program lead and director of contract research Sarah Ives. We’ll hear more about the company's founding story, get perspective on bootstrapping a biotech company, and learn more about their internal and client development programs that cover everything from vaccines, antibodies, and chimeric antigen receptor (CAR) T cell therapies, and which target diseases as varied as influenza, HIV, cancer, and even the SARS-CoV2 Coronavirus. This is the TomorrowScale podcast, hosted by Justin Briggs.

DistributedBio (https://distributedbio.com)

Follow us on Twitter (https://twitter.com/tomorrowscale)

The TomorrowScale Podcast was created by Justin Briggs to showcase scientists and entrepreneurs who are building the future, and to hear their stories from the benches and in the trenches of research & development. The views expressed by the host and guests are their own, and the content of this show should not be considered legal, tax, or investing advice. Thanks to our guests for sharing their time and knowledge with us. Thank you for listening. Please science responsibly.